Baenas, I.
Camacho-Barcia, L.
Granero, R.
Razquin, C.
Corella, D.
Gómez-Martínez, C.
Castañer-Niño, O.
Martínez, J. A.
Alonso-Gómez, Á. M.
Wärnberg, J.
Vioque, J.
Romaguera, D.
López-Miranda, J.
Estruch, R.
Tinahones, F. J.
Lapetra, J.
Serra-Majem, J. L.
Cano-Ibáñez, N.
Tur, J. A.
Martín-Sánchez, V.
Pintó, X.
Gaforio, J. J.
Matía-Martín, P.
Vidal, J.
Vázquez, C.
Daimiel, L.
Ros, E.
Jiménez-Murcia, S.
Dalsgaard, S.
Garcia-Arellano, A.
Babio, N.
Sorli, J. V.
Lassale, C.
García-de-la-Hera, M.
Gómez-García, E.
Zulet, M. A.
Konieczna, J.
Martín-Peláez, S.
Tojal-Sierra, L.
Basterra-Gortari, F. J.
de las Heras-Delgado, S.
Portoles, O.
Muñoz-Pérez, M. Á.
Arenas-Larriva, A. P.
Compañ-Gabucio, L.
Eguaras, S.
Shyam, S.
Fitó, M.
Baños, R. M.
Salas-Salvadó, J. http://orcid.org/0000-0003-2700-7459
Fernández-Aranda, F. http://orcid.org/0000-0002-2968-9898
Funding for this research was provided by:
Instituto de Salud Carlos III (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, CM21/00172, CD22/00171)
Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus
Generalitat Valenciana (AICO/2021/347, PROMETEO/21/2021)
Generalitat de Catalunya- AGAUR (2021-SGR-00824)
Horizon 2020 Framework Programme (847879)
Spanish Ministry of Economy, Industry and Competitiveness (IJC2019-042420-I)
Universitat Rovira i Virgili (2020PMF-PIPF-37)
Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018)
Universitat de Barcelona
Article History
Received: 28 September 2023
Accepted: 7 December 2023
First Online: 13 January 2024
Declarations
:
: JS-S reported receiving research support from the Instituto de Salud Carlos III (ISCIII), Ministerio de Educación y Ciencia, Departament de Salut Pública de la Generalitat de Catalunya, the European Commission; receiving consulting fees or travel expenses from Instituto Danone Spain and Instituto Danone International; receiving nonfinancial support from Hojiblanca, Patrimonio Comunal Olivarero, and Almond Board of California; serving on the board of and receiving grant support through his institution from the International Nut and Dried Foundation; and grants and personal fees from Instituto Danone. ER reported receiving grants, personal fees, and nonfinancial support from the California Walnut Commission during the conduct of the study and grants, personal fees, nonfinancial support from Alexion; grants and personal fees from Sanofi Aventis; personal fees and nonfinancial support from Ferrer International Danone, and Merck Sharp & Dohme; personal fees from Amarin; and nonfinancial support from the International Nut Council outside the submitted work. RE reported receiving grants from Instituto de Salud Carlos III and olive oil for the trial from Fundación Patrimonio Comunal Olivarero\during the conduct of the study and personal fees from Brewers of Europe, Fundación Cerveza y Salud, Interprofesional del Aceite de Oliva, Instituto Cervantes, Pernaud Richar, Fundación Dieta Mediterránea, Wine and Culinary International Forum; nonfinancial support from Sociedad Española de Nutrición and Fundación Bosch y Gimpera; and grants from Uriach Laboratories outside the submitted work. XP reported receiving grants from ISCIII during the conduct of the study, receiving personal fees from Sanofi Aventis, Amgen, Viatris, Amarin, Ferrer Internacional, Daiichi-Sankyo, and Menarini laboratories. SGS has received consulting fees from Abbott Industries Sdn Bhd. FFA and SJM received consultancy and speakers honoraria from Novo Nordisk. The rest of the authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: The PREDIMED-Plus Study was registered at the International Standard Randomized Controlled Trial in 2014 (ISRCT; ). The study protocol and procedures were approved by all participating institutions Research Ethics Committees in accordance with the ethical standards of the Declaration of Helsinki 1964.
: The present study complies with the guidelines for human studies.
: All participants provided written informed consent.